Screening Guidelines (Updated 5/8/2018)
Terms in this set (48)
Abdominal aortic aneurysm screening
Who: Men & ever smoke & ≥65y/o
When: one time
How: ultrasound preferred (previous CT for another reason also counts)
Alcohol misuse: screening and counseling
Who: ≥18 y/o
How: Brief behavioral counseling intervention
Aspirin preventive medication
Who: 50 to 59 y/o & ≥10%-ten yr cardiovascular risk & NOT increased risk for bleeding & ≥10yr life expectancy (and willing to take aspirin daily for ≥10yrs)
(Also 1° prevention for colorectal cancer)
Who: asymptomatic pregnant women
When: 12 to 16 weeks gestation OR at first prenatal visit
How: urine culture
Blood pressure screening
When: every visit
Dx: use ambulatory monitor
BRCA risk assessment and genetic counseling/testing
Who: women w/ family members w/ breast, ovarian, tubal, or peritoneal cancer
Breast cancer preventive medications
Who: women w/ increase risk for breast cancer and low risk for medication SE
Tx: risk reducing drugs such as tamoxifen or raloxifene
How: informed decisionmaking making
Breast cancer screening
Who: women ≥50y/o
When: every 2yrs
Stop: age 74
Who: women during and after pregnancy
How: recommend it
Cervical cancer screening
Who: women 21 to 65y/o
When: every 3yrs
How: pap smear
Who: women 30 to 65y/o who want to lengthen interval
How: pap smear & HPV testing
When: every 5yrs
Who: women & sexually active & ≤24 OR older women at increase risk for infection
Colorectal cancer screening
Who: Adults ≥50 OR 10yr before dx in 1° relative
Stop: 75 y/o
How: Complete colonoscopy every 10 yrs OR Flex sig every 5yr w/ fecal occult blood test every 3yr OR fecal occult blood test every year
Dental caries prevention
Who: infants with primary tooth eruption
Stop: children 5y/o
How: fluoride varnish
Who: children w/ fluoride deficient water supply at 6mo.
How: oral fluoride supplementation
Who: Adolescents 12 to 18y/o and adults including pregnant and postpartum women
The USPSTF recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40 to 70 years who are overweight or obese. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity.
Falls prevention: older adults
The USPSTF recommends exercise interventions to prevent falls in community-dwelling adults 65 years or older who are at increased risk for falls.
Folic acid supplementation
The USPSTF recommends that all women who are planning or capable of pregnancy take a daily supplement containing 0.4 to 0.8 mg (400 to 800 µg) of folic acid.
Gestational diabetes mellitus screening
The USPSTF recommends screening for gestational diabetes mellitus in asymptomatic pregnant women after 24 weeks of gestation.
Gonorrhea prophylactic medication: newborns
The USPSTF recommends prophylactic ocular topical medication for all newborns for the prevention of gonococcal ophthalmia neonatorum.
Gonorrhea screening: women
The USPSTF recommends screening for gonorrhea in sexually active women age 24 years or younger and in older women who are at increased risk for infection.
Healthy diet and physical activity counseling to prevent cardiovascular disease: adults with cardiovascular risk factors
The USPSTF recommends offering or referring adults who are overweight or obese and have additional cardiovascular disease (CVD) risk factors to intensive behavioral counseling interventions to promote a healthful diet and physical activity for CVD prevention.
Hemoglobinopathies screening: newborns
The USPSTF recommends screening for sickle cell disease in newborns.
Hepatitis B screening: nonpregnant adolescents and adults
The USPSTF recommends screening for hepatitis B virus infection in persons at high risk for infection.
Hepatitis B screening: pregnant women
The USPSTF strongly recommends screening for hepatitis B virus infection in pregnant women at their first prenatal visit.
Hepatitis C virus infection screening: adults
The USPSTF recommends screening for hepatitis C virus (HCV) infection in persons at high risk for infection. The USPSTF also recommends offering one-time screening for HCV infection to adults born between 1945 and 1965.
HIV screening: nonpregnant adolescents and adults
The USPSTF recommends that clinicians screen for HIV infection in adolescents and adults ages 15 to 65 years. Younger adolescents and older adults who are at increased risk should also be screened.
HIV screening: pregnant women
The USPSTF recommends that clinicians screen all pregnant women for HIV, including those who present in labor who are untested and whose HIV status is unknown.
Hypothyrodism screening: newborns
The USPSTF recommends screening for congenital hypothyroidism in newborns.
Intimate partner violence screening: women of childbearing age
The USPSTF recommends that clinicians screen women of childbearing age for intimate partner violence, such as domestic violence, and provide or refer women who screen positive to intervention services. This recommendation applies to women who do not have signs or symptoms of abuse.
Lung cancer screening
The USPSTF recommends annual screening for lung cancer with low-dose computed tomography in adults ages 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.
Obesity screening and counseling: adults
The USPSTF recommends screening all adults for obesity. Clinicians should offer or refer patients with a body mass index of 30 kg/m2 or higher to intensive, multicomponent behavioral interventions.
Obesity screening: children and adolescents
The USPSTF recommends that clinicians screen for obesity in children and adolescents 6 years and older and offer or refer them to comprehensive, intensive behavioral interventions to promote improvements in weight status.
Osteoporosis screening: women
The USPSTF recommends screening for osteoporosis in women age 65 years and older and in younger women whose fracture risk is equal to or greater than that of a 65-year-old white woman who has no additional risk factors.
Phenylketonuria screening: newborns
The USPSTF recommends screening for phenylketonuria in newborns.
Preeclampsia prevention: aspirin
The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication after 12 weeks of gestation in women who are at high risk for preeclampsia.
The USPSTF recommends screening for preeclampsia in pregnant women with blood pressure measurements throughout pregnancy.
Rh incompatibility screening: first pregnancy visit
The USPSTF strongly recommends Rh (D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.
Rh incompatibility screening: 24-28 weeks' gestation
The USPSTF recommends repeated Rh (D) antibody testing for all unsensitized Rh (D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh (D)-negative.
Sexually transmitted infections counseling
The USPSTF recommends intensive behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections.
Skin cancer behavioral counseling
The USPSTF recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.
Statin preventive medication: adults ages 40-75 years with no history of CVD, 1 or more CVD risk factors, and a calculated 10-year CVD event risk of 10% or greater
The USPSTF recommends that adults without a history of cardiovascular disease (CVD) (i.e., symptomatic coronary artery disease or ischemic stroke) use a low- to moderate-dose statin for the prevention of CVD events and mortality when all of the following criteria are met: 1) they are ages 40 to 75 years; 2) they have 1 or more CVD risk factors (i.e., dyslipidemia, diabetes, hypertension, or smoking); and 3) they have a calculated 10-year risk of a cardiovascular event of 10% or greater. Identification of dyslipidemia and calculation of 10-year CVD event risk requires universal lipids screening in adults ages 40 to 75 years.
Tobacco use counseling and interventions: nonpregnant adults
The USPSTF recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and U.S. Food and Drug Administration (FDA)-approved pharmacotherapy for cessation to adults who use tobacco.
Tobacco use counseling: pregnant women
The USPSTF recommends that clinicians ask all pregnant women about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant women who use tobacco.
Tobacco use interventions: children and adolescents
The USPSTF recommends that clinicians provide interventions, including education or brief counseling, to prevent initiation of tobacco use in school-aged children and adolescents.
Tuberculosis screening: adults
The USPSTF recommends screening for latent tuberculosis infection in populations at increased risk.
Syphilis screening: nonpregnant persons
The USPSTF recommends screening for syphilis infection in persons who are at increased risk for infection.
Syphilis screening: pregnant women
The USPSTF recommends that clinicians screen all pregnant women for syphilis infection.
Vision screening: children
The USPSTF recommends vision screening at least once in all children ages 3 to 5 years to detect amblyopia or its risk factors.